Profile
Nancy Sacco is a former Head of Clinical Development at AnaptysBio, Inc. and a former Vice President and Head of Clinical Development at Xentria, Inc. She also served as the Chief Development Officer at Hexima Ltd.
in 2021-2022.
Sacco holds a doctorate degree from West Virginia University School of Medicine.
Former positions of Nancy Sacco
| Companies | Position | End |
|---|---|---|
| HEXIMA LIMITED | Corporate Officer/Principal | 2022-10-14 |
Xentria, Inc.
 Xentria, Inc. BiotechnologyHealth Technology Xentria, Inc. is a biopharmaceutical company founded in 2020 that specializes in creating collaborations and partnerships to advance drug development. The company is based in Chicago, IL. The company is dedicated to delivering customized approaches to drug innovation through patient engagement and effective partnerships. Xentria is focused on becoming a critical leader in the biopharma industry through a strong portfolio of biologic products for patients. | Chief Tech/Sci/R&D Officer | - |
| ANAPTYSBIO, INC. | Chief Tech/Sci/R&D Officer | - |
Training of Nancy Sacco
| West Virginia University School of Medicine | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| ANAPTYSBIO, INC. | Health Technology |
| HEXIMA LIMITED | Health Technology |
| Private companies | 1 |
|---|---|
Xentria, Inc.
Xentria, Inc. BiotechnologyHealth Technology Xentria, Inc. is a biopharmaceutical company founded in 2020 that specializes in creating collaborations and partnerships to advance drug development. The company is based in Chicago, IL. The company is dedicated to delivering customized approaches to drug innovation through patient engagement and effective partnerships. Xentria is focused on becoming a critical leader in the biopharma industry through a strong portfolio of biologic products for patients. | Health Technology |
- Stock Market
- Insiders
- Nancy Sacco
